The global JE (Japanese encephalitis) vaccine market was estimated to value at USD 215.15 million in 2024. It is expected to grow at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2025-2034, reaching a value of USD 348.34 million by 2034. This growth is fueled by increasing awareness of Japanese encephalitis (JE) across endemic regions, rising government and NGO...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek